Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
Authors:
The OpenSAFELY Collaborative, Edward P.K. Parker, Elsie M.F. Horne, William J. Hulme, John Tazare, Bang Zheng, Shalini Santhakumaran, Retha Steenkamp and Dorothea Nitschet al.